… A systematic search was conducted using Excerpta Medica Database … therapies and systemic
therapies (targeted chemotherapy, redifferentiation therapy, immunotherapy, gene therapy…

… Anaplastic thyroid cancer is an uncommon, typically lethal malignancy of older adults with
no effective systemic therapy. The mean survival time is usually less than 6 months from the …

… levels before initiation of systemic therapy despite structurally PD. … systemic therapy, and
one patient did not have sufficient data to determine TG trends while receiving systemic therapy. …

… of thyroid cancers has led to considerable gains in gene-specific systemic therapies for
many cancers. … follicular-derived thyroid cancers and medullary thyroid cancer and highlights …

… Introduction: Management of recurrent differentiated thyroid cancer (DTC) may include
surgery, radioactive iodine (RAI), and external beam radiotherapy (EBRT). Systemic therapy may …

… of more effective systemic therapies is necessary. Inclusion of anaplastic thyroid cancer
patients in … will be helpful for further understanding systemic treatment options. Until better …

… about therapy, such as palliative surgery of metastases, external beam radiation of bone
metastases, chemoembolization of liver metastases or administration of systemic therapy like …

… of a locally advanced medullary thyroid cancer that is not … ) have been used when a systemic
therapy is indicated for large … thyroid cancer with emphasis on current targeted therapies …

… Prior systemic therapy including TKI was allowed, however not RAF, MEK, EGFR inhibitors.
Median treatment duration was 27 weeks. PR by RECIST was achieved in 11 (23%) patients, …

… therefore, identification of these rearrangements might have direct therapeutic relevance
to patients with thyroid cancer. Debate exists regarding the clinical implications of individual …